Methane

Methane

SCHEMBL5743567

C.CN1CCCCC1O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18460252 0.97
SCHEMBL99053 0.97
Hydrochloric Acid SCHEMBL28238151 0.95
SCHEMBL20144349 0.95
Methane SCHEMBL2578408 0.92
SCHEMBL487463 0.89
SCHEMBL13456720 0.89
SCHEMBL8433309 0.89
SCHEMBL487464 0.89
Hydrochloric Acid SCHEMBL28237384 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6756467-B2 POLYURETHANE SYSTEMS FOR USE AS ORTHOPAEDIC SPLINTING; VISCOSITY; SHELL LIFE BSN MEDICAL, INC. 2004-06-29 US claimed
US-20020128421-A1 Curable compositions SHELVEY MICHAEL FRANCIS (GB) 2002-09-12 US claimed
EP-0850256-B1 CURABLE COMPOSITIONS BSN MEDICAL INC (US) 2002-07-17 EP claimed
US-6353077-B2 A WATER CURABLE ISOCYANATE FUNCTIONALIZED PREPOLYMER AND A FIRST AND SECOND CATALYST COMPONENT CHARACTERIZED IN THAT THE FIRST AMINE CATALYST IS COVALENTLY BOUND-IN TO THE PREPOLYMER AND SECOND CATALYST IS NOT CHEMICALLY BOUND BSN MEDICAL, INC. 2002-03-05 US claimed
US-20010005744-A1 CURABLE COMPOSITIONS BSN MEDICAL, INC. 2001-06-28 US claimed
EP-0850256-A1 CURABLE COMPOSITIONS Smith &amp; Nephew plc (GB) 1998-07-01 EP claimed
WO-1997010275-A1 CURABLE COMPOSITIONS SMITH & NEPHEW PLC (GB) 1997-03-20 WO claimed
WO-2025134877-A1 KIT AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2025-06-26 WO disclosed
US-11491177-B1 Noninvasive medical procedure for destruction of cancer and precancerous cells SCHEIBER LANE (US) 2022-11-08 US disclosed
EP-2617779-B1 Low odor environmentally-friendly nano-pigment inkjet ink composition JETBEST CORP (TW) 2014-11-05 EP disclosed
US-8710118-B2 Nano-pigment inkjet ink composition that has a low odor and is environmentally-friendly JETBEST CORPORATION (TW) 2014-04-29 US disclosed
US-20130190421-A1 LOW ODOR ENVIRONMENTALLY-FRIENDLY NANO-PIGMENT INKJET INK COMPOSITION JETBEST CORPORATION (TW) 2013-07-25 US disclosed
EP-2617779-A1 Low odor environmentally-friendly nano-pigment inkjet ink composition JETBEST Corporation (TW) 2013-07-24 EP disclosed
WO-2001023618-A2 COMPOSITIONS AND METHODS FOR REDUCING OLIGONUCLEOTIDE HYBRIDIZATION AND PRIMING SPECIFICITY QIAGEN GENOMICS, INC. (US) 2001-04-05 WO disclosed
US-6060488-A ANTICARCINOGENIC AGENTS; POSTMENOPAUSAL CANCER OF BREASTS, UTERUS, CERVIX ELI LILLY AND COMPANY (US) 2000-05-09 US disclosed
WO-1999015521-A1 BENZOTHIOPHENES ELI LILLY AND COMPANY (US) 1999-04-01 WO disclosed
EP-0905132-A1 Benzothiophenes ELI LILLY AND COMPANY (US) 1999-03-31 EP disclosed
EP-0901996-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINES Mitsui Chemicals, Inc. (JP) 1999-03-17 EP disclosed
EP-0850256-A1 CURABLE COMPOSITIONS Smith &amp; Nephew plc (GB) 1998-07-01 EP disclosed
WO-1997010275-A1 CURABLE COMPOSITIONS SMITH & NEPHEW PLC (GB) 1997-03-20 WO disclosed